Abstract

A comparison was made of the potency of live lentogenic Newcastle disease vaccines using a multipoint challenge assay. In general, La Sota vaccines gave better protection than B1 vaccines and both were superior to products made from the Ulster 2C strain. However, variation was found within products prepared from the same strains, depending on their source. Two novel types of vaccine derived from the conventional B1 or La Sota strains were as protective as La Sota vaccines and a third gave protection similar to that of B1 vaccines.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.